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Abstract
Background: Continuing medical education (CME) in earlier cancer diagnosis was launched in Denmark in 2012 as
part of the Danish National Cancer Plan. The CME programme was introduced to improve the recognition among
general practitioners (GPs) of symptoms suggestive of cancer and improve the selection of patients requiring
urgent investigation. This study aims to explore the effect of CME on GP knowledge about cancer diagnosis,
attitude towards own role in cancer detection, self-assessed readiness to investigate and cancer risk assessment of
urgently referred patients.
Methods: We conducted a before-after study in the Central Denmark Region including 831 GPs assigned to one of
eight geographical clusters. All GPs were invited to participate in the CME at three-week intervals between clusters.
A questionnaire focusing on knowledge, attitude and clinical vignettes was sent to each GP one month before and
seven months after the CME. The GPs were also asked to assess the risk of cancer in patients urgently referred to a
fast-track cancer pathway during an eight-month period. CME-participating GPs were compared with reference
(non-participating) GPs by analysing before-after differences.
Results: One quarter of all GPs participated in the CME. 202 GPs (24.3 %) completed both the baseline and the
follow-up questionnaires. 532 GPs (64.0 %) assessed the risk of cancer before the CME and 524 GPs (63.1 %)
assessed the risk of cancer after the CME in urgently referred consecutive patients. Compared to the reference
group, CME-participating GPs statistically significantly improved their understanding of a rational probability of
diagnosing cancer among patients urgently referred for suspected cancer, increased their knowledge of cancer
likelihood in a 50-year-old referred patient and lowered the assessed risk of cancer in urgently referred patients.
Conclusions: The standardised CME lowered the GP-assessed cancer risk of urgently referred patients, whereas the
effect on knowledge about cancer diagnosis and attitude towards own role in cancer detection was limited. No
effect was found on the GPs’ readiness to investigate. CME may be effective for optimising the interpretation of
cancer symptoms and thereby improve the selection of patients for urgent cancer referral.
Trial registration: NCT02069470 on ClinicalTrials.gov. Retrospectively registered, 1/29/2014.
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Background
Increasing evidence indicates that timely detection can
improve cancer survival [1–3]. Urgent referral to cancer
investigation was established in Denmark in 2008 [4],
but successful effect of such initiative depends on the
patient referral patterns in general practice. As 85 % of
cancer patients initially present symptoms to their
general practitioner (GP) [3, 5], timely referral may be
improved by optimising the GPs’ recognition and interpret-
ation of symptoms as this might lead to earlier diagnosis of
cancer. A major challenge for the GP is that most of the
symptoms which could signal cancer have a benign cause
[6]. Each time such a patient is seen in consultation, the
GP must evaluate the risk of cancer, consider the need for
investigations and assess the degree of urgency [7]. There-
fore, the GP operates under an integrated risk model which
considers both basis risk (e.g. patient age, gender and fam-
ily history) and added risk (e.g. presence or absence of
symptoms, clinical findings and test results) [8]. The latest
Danish national cancer plan, which was adopted in 2012,
launched a continuing medical education (CME)
programme in earlier cancer diagnosis to support and fur-
ther develop the GPs’ decision-making strategies for refer-
ral. A specific CME intervention was developed [9] and
implemented based on the available evidence [10–12]. The
CME focused on several issues, including the diagnostic
process in general practice, symptom risk assessment tools
(RATs) [13, 14] and risk of false reassurance when
interpreting the results of chest X-rays [15, 16] and
gynaecological examinations [14].
Enhanced knowledge may provide improved under-
standing of diagnosing cancer, which may change the
GP’s attitude towards own role in cancer detection. Still,
attitudes and readiness to investigate are also influenced
by the cultural settings and the organisational system in
which the GP operates as a gatekeeper to secondary care
[17, 18]. However, to our knowledge, no former studies
have measured the effect of a specific CME on know-
ledge, attitude and intentions in the same study, with the
same GP participants and intervention.
The aim of this study was 1) to analyse the effect of a
standardised CME in earlier cancer diagnosis on the
GPs’ knowledge about cancer diagnosis and 2) to assess
the GPs’ attitudes towards own role in cancer detection.
We also intended 3) to analyse whether the CME chan-
ged the GPs’ self-assessed readiness to investigate hypo-
thetical symptomatic patients and 4) to assess the
impact of the CME on the GPs’ cancer risk assessment
of patients urgently referred for cancer suspicion.
Methods
Setting
The study was performed in one of five Danish regions,
the Central Denmark Region, with 1.27 million
inhabitants, 417 general practices and 831 GPs. In
Denmark, GPs own their own practice and operate
under a publicly funded mixed remuneration scheme
based on a collective agreement with the Danish regions
[19]. All GPs have a contract with the public health in-
surance, which ensures more than 90 % of their earn-
ings. Part of the agreement includes remuneration for
participation in CME. Most citizens (98 %) are listed
with a specific general practice, and the GP must first be
consulted if a citizen needs (free) medical advice, except
for emergencies. Therefore, GPs act as gatekeepers to
hospitals and private specialists.
Intervention: continuing medical education
The planning of the CME was initiated by a multidiscip-
linary team. A working group was established to oper-
ationalise the CME, which has been described elsewhere
[9]. The CME consisted of a 3-h session with a multifa-
ceted teaching approach [12]. The key aim of the CME
was to optimise cancer-related referrals from general
practice to hospitals by reducing the GPs’ referral
threshold and to increase their knowledge about cancer
symptoms in an attempt to identify underlying cancers
at an earlier stage. Barriers on GP-level were addressed
in a reflective debate among the GPs [9]. All GPs were
provided with the available risk assessment charts on
lung, colorectal, ovarian and prostate cancer [13, 14].
However, the CME focused on earlier detection of all
cancer types. The CME was conducted by a team of six
persons with different health-care backgrounds [9].
Overall study design and recruitment of GPs
To increase CME attendance, geographical accessibility
was ensured by conducting eight local meetings. All GPs
in the region were assigned to one of eight clusters
based on geography. All GP clusters were invited to the
CME in the period of September 2012 to May 2013 with
3-week intervals. The Regional Cancer Quality Unit
decided the random order in which the clusters were of-
fered the CME intervention. The CME was announced
by mail invitations two months and again one month
before the CME was planned to take place. Each GP was
registered upon arrival at the CME [9]. We performed a
before-after study embedded in a stepped-wedge enrol-
ment of the CME intervention.
Questionnaire data
GPs who had already responded to a similar question-
naire (International Cancer Benchmarking Partnership
study, module-3 (ICBP-M3)) [20] in September 2012
were excluded, and 751 GPs were invited to complete
the baseline questionnaire. The GPs received an e-mail
invitation with a link to the online survey one month be-
fore their CME was scheduled to take place. GPs who
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responded to the baseline survey were invited to
complete the follow-up questionnaire seven months
after their CME date. Reminders were sent to non-
respondents 14 days after the primary invitation in both
surveys. Remuneration was 33 euros for completing the
baseline questionnaire and 17 euros for completing the
follow-up questionnaire.
The online questionnaire consisted of single items and
vignettes. The items were developed based on the ele-
ments included in the CME to measure the CME effect
on knowledge about cancer diagnosis (6 items), attitude
towards own role in cancer detection (7 items) and atti-
tude towards practical aspects of urgent referral [9]. The
vignettes were validated and tested in the ICBP-M3 pro-
ject [20]. They measured readiness to investigate when a
hypothetical patient presented with symptoms suggestive
of lung cancer (two vignettes), colorectal cancer (two
vignettes) or ovarian cancer (one vignette). The English
versions of the vignettes were translated into Danish [9].
GP knowledge
GP knowledge about cancer diagnoses comprised 1) can-
cer as a condition with a low prevalence (one item), 2)
positive predictive values (PPVs) for cancer of selected
symptoms (two items), 3) diagnostic pitfalls (two items)
and 4) initial cancer presentation (one item). The word-
ing of each item initiated with “what is the likelihood
that…” or ‘what is the proportion of…” and the GP
was requested to state the response as a percentage
(0–100 %). Based on the available evidence, the research
group agreed on the most appropriate response (MAR)
test area as a percentage range for each of the six items
(Additional file 1).
GP attitude
The GP’s attitude towards own role in cancer detection,
which is related to the GP’s interpretation of the balance
between benefits and harms of early diagnostic testing,
was measured by statements addressing the concerns
about 1) overusing healthcare services or distressing the
patient when an urgent referral does not result in a can-
cer diagnosis (two items), 2) risking over-diagnosis when
ordering tests (one item), 3) communicating cancer risk
with patient and fast-track coordinator (two items) and
4) exploring the GP’s referral threshold for urgent cancer
investigation (two items). The GP’s attitude towards
practical aspects of urgent referral was measured by
statements addressing the GP’s experience with 1) use of
urgent referral (complicated and/or time-consuming), 2)
delivery of written patient instructions and 3) use of in-
formation from the online cancer guideline. Responses
were given on a 5-point Likert scale. The research group
agreed to dichotomise the responses for each attitude
item based on the two most appropriate responses (i.e.
agree/strongly agree) versus the remaining three re-
sponse options including neutral.
GP readiness to investigate
The GPs were presented with two randomly chosen vi-
gnettes at baseline and another two vignettes at follow-up.
Each vignette included a description of a patient’s initial
symptom presentation and asked the GP to decide which
action to take. If the GP chose an expectant strategy, the
case developed further and the patient returned with new
and more severe symptoms [20] (Additional file 2).
GP cancer risk assessment of urgently referred patients
All 831 GPs in the Central Denmark Region received a
pad with 25 one-page forms. The GPs were requested to
complete a form each time a patient was urgently re-
ferred for suspected cancer [9, 21] during an 8-month
period (1 September 2012–1 May 2013). Patients investi-
gated in a fast-track pathway were also identified in the
patient administrative system for hospital care. If the GP
form was missing for a patient identified in the register,
the GP received a form for that particular patient and
was requested to complete it.
The form included information about the patient’s per-
sonal identification number, the date of referral and the
GP’s assessment of the patient’s risk of cancer (0–100 %)
at the time of the referral [9]. Remuneration was 100
euros for completion of forms during the 8-month
period. The form was processed using Teleform Version
8.0 (Cardiff Software Inc., San Marcos, CA, USA). Hand-
written data were coded by the first author (BST) before
scanning [22]. All optically scanned data were checked
for outliers and discrepancies.
Analyses
GPs were divided into a CME-participating group and a
non-participating reference group. The time point for a
CME-session was identical with the point for crossover
from before to after, and thus it constituted a step in the
before-after models. Data were collected before and after
the CME to provide paired responses for each outcome
variable. GP characteristics were described for the entire
study base, for the GPs who completed baseline and
follow-up surveys and for GPs who assessed cancer risk
in referred patients.
Responses to attitude and knowledge items were pre-
sented as proportions of the GPs who responded most
appropriately (Additional File 1 for knowledge items).
Attitude and knowledge levels before and after CME were
compared within and between groups by conditional
fixed-effects Poisson regression based on cluster-robust
standard errors (SEs). Within-individual differences were
used to estimate effects, and each GP was used as own
control. We used the robust SEs to relax the assumption
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behind the Poisson model that the variance was equal to
the mean [23]. The SEs were corrected for clustering at
step level. Effects within groups were reported as risk
ratios (RRs). Comparison of effects between groups was
reported as a ratio of RRs.
GP readiness to investigate was analysed through the
proportions of vignettes where the GP made a definitive
action after first and after second phase. Because of the
binary data format, comparisons of responses before and
after CME were performed by using multilevel mixed-
effects logistic regression to ensure that within-GP corre-
lations were taken into account [24]. The model allowed
for random effects at GP level. The time of observation
(before and after CME) was treated as a fixed-effect vari-
able. The effects within groups were reported as odds
ratios (ORs). Comparison of effects between groups was
reported as a ratio of the ORs. The analyses were adjusted
for study step and type of vignette.
GP cancer risk assessment of urgently referred patients
was described as mean risk with 95 % confidence interval
(CI) and median with interquartile interval (IQI), as the
population was not normally distributed. Comparisons of
risk assessment before and after CME within and between
groups were performed using multilevel mixed-effects lin-
ear regression. The model was fitted to take into account
within-GP correlations and GP clustering in clinics. The
time of observation (before and after CME) was treated as
a fixed effect variable. To satisfy the assumptions of the
model and be able to compare mean risks, the dependent
variable was square root transformed. The analyses were
adjusted for study step, patient gender and patient age.
All statistical analyses were performed using Stata




The study base consisted of 831 GPs (Table 1). A total
of 197 GPs (23.7 %) participated in the CME; they did
not differ from the study base in age, but the CME-
participating GPs were less likely to be male and solo
GPs. Baseline and follow-up questionnaires were com-
pleted by 202 GPs (24.3 %). Of these, the CME-
participating GPs were younger, less likely to be male
and solo GPs, whereas reference GPs were younger, less
likely to be female, but they did not differ in clinic type
from the study base (Table 1). Due to technical difficul-
ties with the online survey, 6 GPs were not able to
complete both baseline and follow-up vignettes and were
excluded from the vignette analyses (Fig. 1).
Cancer risk assessment of urgently referred patients
was completed by 532 GPs (64.0 %) before the CME and
524 GPs (63.1 %) after the CME. The CME-participating
GPs were less likely to be male and solo GPs, but did
not differ in age, whereas the reference GPs did not dif-
fer in age, gender and clinic type compared to the study
base (Table 1).
Table 1 Characteristics of GPs. Age, gender and type of clinic are shown for all GPs in the Central Denmark Region (study base), GPs
responding to the knowledge and attitude questionnaire, GPs completing the vignettes and GPs assessing risk of cancer for
continuous patients. GPs are divided into the CME-participating GPs and the reference GPs
GP characteristics
N (%) Mean age Years
(95 % CI)
Proportion of males %
(95 % CI)
Proportion of solo GPs %
(95 % CI)
Study base
Total 831 (100) 52.3 (51.7; 52.8) 54.3 (50.9; 57.7) 24.1 (21.2; 27.0)
Reference GPs 634 (76.3) 52.4 (51.7; 53.0) 56.5 (52.6; 60.3) 26.0 (22.6; 29.4)
CME-participating GPs 197 (23.7) 51.9 (50.8; 53.0) 47.2 (40.2; 54.2) 17.8 (12.4; 23.2)
GPs that completed knowledge and attitudes items
Reference GPs 121 (19.1) 49.8 (48.3; 51.4) 57.9 (48.9; 66.8) 24.0 (16.3; 31.7)
CME-participating GPs 81 (41.1) 50.7 (48.8; 52.5) 46.9 (35.8; 58.0) 18.5 (9.9; 27.2)
GPs that completed vignettes
Reference GPs 116 (18.3) 49.9 (48.4; 51.5) 58.6 (49.5; 67.7) 23.3 (15.5; 31.1)
CME-participating GPs 80 (40.6) 50.5 (48.7; 52.4) 47.5 (36.3; 58.7) 18.8 (10.0; 27.5)
GPs that assessed risk of cancer on urgently referred patients
Reference GPs, before 384 (60.6) 51.6 (50.8; 52.4) 52.6 (47.6; 57.6) 26.8 (22.4; 31.3)
Reference GPs, after 364 (57.4) 51.7 (50.8; 52.6) 53.6 (48.4; 58.7) 22.3 (18.0; 26.5)
CME-participating GPs, before 148 (75.1) 51.6 (50.3; 52.9) 45.9 (37.8; 54.1) 17.6 (11.4; 23.8)
CME-participating GPs, after 160 (81.2) 51.9 (50.6; 53.1) 46.9 (39.1; 54.7) 15.6 (9.9; 21.3)
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CME effect on GP attitude
The CME-participating GPs showed a statistically sig-
nificant appropriate change in 2 of 7 items addressing
the attitude towards own role in cancer detection com-
pared to the reference GPs (Table 2). After the CME, the
participating GPs were more likely to disagree with the
following two statements: ‘If a patient referred by me to
a cancer fast-track pathway turns out not to have cancer,
unnecessary strain has been placed on the patient’ and
‘The more of the patients referred by me to a cancer
fast-track pathway turn out to have cancer, the better a
doctor I am’.
No differences were found for the 6 items addressing
attitude towards practical aspects of urgent referral for
suspected cancer (not reported in table).
CME effect on GP knowledge about cancer diagnosis
The CME-participating GPs showed a statistically sig-
nificant appropriate change in only 1 out of 6 items
addressing GP knowledge about cancer diagnosis
compared to the reference GPs. They increased their
knowledge regarding the likelihood that a patient
aged 50 would have cancer at the time of urgent re-
ferral (Table 3). Although not significantly, the CME-
participating GPs tended to have increased knowledge
compared to the reference GPs on the likelihood that
a patient aged 40 and above would have colorectal
cancer the first time the patient presented unintended
weight loss and newly onset constipation in general
practice (Table 3).
CME effect on GP readiness to investigate (vignettes)
The proportion of vignettes where GPs made a definitive
action at the end of the second phase has been signifi-
cantly increased within the CME-participating group,
but no significant differences in before-after changes in
self-assessed readiness to investigate were found between
the two groups (Table 4).
CME effect on GP cancer risk assessment of urgently
referred patients
The CME-participating GPs statistically significantly
lowered their assessed risk of cancer in urgently referred
patients compared to the reference GPs (Table 5).
Discussion
Main findings
We found that one fourth of the GPs participated in a
CME on earlier cancer diagnosis. The standardised CME
lowered the GP-assessed cancer risk of urgently referred
patients and showed a limited effect on the GPs’ know-
ledge about cancer diagnosis and attitude towards own
role in cancer detection. The CME had no effect on the
GPs’ self-assessed readiness to investigate or the GPs’
attitude towards practical aspects of urgent referral.
Strength and limitations
The before-after design with geographical clusters of
GPs receiving CME in a random order three weeks a
part made it possible to perform a robust evaluation
with correction for baseline measures of a rather
Study base
831 GPs from the Central Denmark Region 
(634 reference GPs -197 CME-participating GPs)
751 [90.4%]2 GPs invited to baseline 
questionnaire 1 month before CME date  
246 (32.7%) [29.6%]2 GPs completed 
baseline survey AND invited to follow-up  
No response n=505 (67.3%)
baseline and follow-up surveys.
(121 Reference GPs and 81 CME-
participating GPs)
Excluded n=801 [9.6%]2
No response n=44 (17.9%)
referred to a cancer fast-track pathway from 1 Sept. 2012 -1 May 2013. 
page forms. 
(384 Reference GPs =1740 one-page forms)
(148 CME-participating GPs = 610 one-page forms)
After CME date: 524 (63.1%) GPs completed 2114 one-
page forms. 
(364 Reference GPs = 1276 one-page forms)
(160 CME-participating GPs = 838 one-page forms)
Data on GP cancer risk assessments on urgently referred patients Data on GP knowledge, attitude and 
readiness to investigate 
questionnaire seven months after CME date
Before CME date: 532 (64.0%) GPs completed 2350 one-
831 GPs requested to complete a one-page form each time a patient was  
2023 (82.1%) [24.3%]2 GPs completed both 
Fig. 1 Flowchart of the data collection. The left part illustrates the GP completion of questionnaires at baseline (1 month before the CME) and at
follow-up (7 months after the CME). The right part illustrates the consecutive GP completion of one-page forms, including assessed risk of cancer in
referred patients before and after the CME. 1GPs who completed a similar questionnaire in the ICBP study, module 3, September 2012. 2Proportion of
study base. 3196 GPs completed both baseline and follow-up vignettes (116 reference GPs and 80 CME-participating GPs). 6 GPs were lost to follow-up
due to a technical failure of the online survey system
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Table 2 The CME effect on GPs’ attitude towards own role in cancer detection. The proportion of GPs responding most appropriately is shown for each of the items; one month
before (Before) and seven months after (After) the CME. GPs are divided into two groups: CME-participating group and reference group. An effect within a group is
shown as a risk ratio (RR0 for the Reference group; RR1 for the CME-participating group). Comparisons between groups are shown as ratio of risk ratios (RR1/RR0)
Reference group CME-Participating group Comparison
between
groups
N = 121 N = 81
Most appropriate answers Before After Before vs. after Before After Before vs. after RR1/RR0 (p*)
% (n) % (n) RR0 (p*) % (n) % (n) RR1 (p*)
If a patient referred by me to a cancer
fast-track pathway turns out not to
have cancer, it is overuse of health
services.
Strongly disagree - disagree 86.8 (105) 84.3 (102) 0.97 (0.419) 81.5 (66) 87.7 (71) 1.08 (0.163) 1.11 (0.241)
If a patient referred by me to a cancer
fast-track pathway turns out not to
have cancer, unnecessary strain has
been placed on the patient.
Strongly disagree - disagree 83.5 (101) 79.3 (96) 0.95 (0.221) 75.3 (61) 79.0 (64) 1.05 (0.275) 1.11 (<0.001)
The more of the patients referred by
me to a cancer fast-track pathway
turn out to have cancer, the better
a doctor I am.
Strongly disagree - disagree 57.9 (70) 62.0 (75) 1.07 (0.224) 59.3 (48) 79.0 (64) 1.33 (0.003) 1.24 (0.013)
I am a good doctor when I refer a
patient to a cancer fast-track
pathway based on a reasonable
suspicion, as it quickly clarifies
the suspicion.
Strongly agree- agree 81.0 (98) 81.8 (99) 1.01 (0.823) 86.4 (70) 82.7 (67) 0.96 (0.397) 0.95 (0.537)
I am reluctant to order tests
because of the risk of
over-diagnosis.
Strongly disagree - disagree 75.2 (91) 75.2 (91) 1.00 (1.000) 71.6 (58) 75.3 (61) 1.05 (0.308) 1.05 (0.314)
I find it hard to mention cancer
suspicion to a patient with
alarm symptoms of cancer.
Strongly disagree - disagree 81.0 (98) 83.5 (101) 1.03 (0.402) 74.1 (60) 75.3 (61) 1.02 (0.704) 1.00 (0.813)
I feel well prepared to
communicate with the
cancer pathway coordinators.
Strongly agree- agree 82.6 (100) 78.5 (95) 0.95 (0.224) 79.0 (64) 77.8 (63) 0.98 (0.806) 1.03 (0.697)













Table 3 The CME effect on GPs’ knowledge about cancer diagnosis. The proportion of GPs responding most appropriately (MAAA) is shown for each item; one month before
(Before) and seven months after (After) the CME. GPs are divided into two groups: CME-participating group and reference group. An effect within a group is shown as a risk ratio
(RR0 for the Reference group; RR1 for the CME-participating group). Comparisons between groups are shown as ratio of risk ratios (RR1/RR0)
Reference group CME Participating group Comparison
between
groups
N = 121 N = 81
MAAA Before After Before vs. after Before After Before vs. after RR1/RR0 (p*)
% (n) % (n) RR0 (p*) % (n) % (n) RR1 (p*)
What is the likelihood that a 50-year-old
patient having cancer at the time you
choose to refer the patient to a cancer
fast-track pathway?
2–10 % 29.8 (36) 38.8 (47) 1.31 (<0.001) 23.5 (19) 65.4 (53) 2.79 (<0.001) 2.13 (0.009)
What is the likelihood that a patient
aged 40 years or more, who is smoker,
has lung cancer the second time s/he
presents with haemoptysis in your
practice?
5–20 % 33.1 (40) 34.7 (42) 1.05 (0.698) 33.3 (27) 58.0 (47) 1.74 (0.010) 1.63 (0.160)
What is the likelihood that a patient
aged 40 years or more has colorectal
cancer the first time that s/he presents
with unintended weight loss and new
onset of constipation in your practice?
2–6 % 8.3 (10) 9.9 (12) 1.19 (0.039) 6.2 (5) 28.4 (23) 4.6 (<0.001) 3.83 (0.055)
What is the likelihood that a lung
cancer cannot be detected on a chest
x-ray at the time of diagnosis?
≥15 % 81.8 (99) 86.0 (104) 1.05 (0.741) 76.5 (62) 81.5 (66) 1.06 (0.243) 1.07 (0.309)
What is the proportion of patients with
colorectal cancer who presented an
alarm symptom as the first sign of the
disease to his/her general practitioner?
≤60 % 81.8 (99) 86.0 (104) 1.05 (0.449) 82.7 (67) 90.1 (73) 1.09 (0.006) 1.04 (0.614)
What is the proportion of patients with
ovarian cancer who can be detected
by a pelvic examination (palpation) in
general practice at the time of diagnosis?
≤41 % 90.0 (110) 94.2 (114) 1.04 (0.078) 85.2 (69) 92.6 (75) 1.09 (0.012) 1.05 (0.322)













naturalistic experiment. Randomisation at an individual
GP level was considered unfeasible due to interaction of
GPs within practices. Furthermore, it was preferred to
invite all GPs from one cluster to the same CME meet-
ing because geographical acceptability had high priority,
and two meetings in each cluster area was found un-
favourable due to financial and time costs.
A principal strength is the well-defined study popula-
tion of GPs described by age, gender and clinic type.
Other factors of interest could have been the socio-
demographic characteristics of the patient population.
The geographical clusters were divided into CME-
participating and reference GPs based on the GP’s choice
of participation. Spill-over effect from the CME-
participating GPs to the reference GPs could have
underestimated the actual effect of the CME. Other ini-
tiatives could also have influenced the change from base-
line to follow-up, although no competitive regional
courses were offered in the study period. We attempted
to correct for influence of calendar time by including
study steps into the modelling of data.
A major strength is the standardised CME with a de-
tailed description of CME elements, training process and
context, which will allow primary health care settings else-
where to use our findings and adapt them to their context.
Data was collected through a questionnaire developed
ad hoc to assess the effect of the CME. The question-
naire included single items specifically targeting the con-
tent of the CME. This adaptation may be a potential
weakness compared with instruments with established
measurement properties, but we found it necessary
because relevant validated measures were sparse. The
questionnaire was developed in consideration of qualita-
tive and quantitative pilot studies [9]. As paired items
were analysed before and after the CME, the possible
bias from using ad hoc items was diminished.
The vignettes were developed and validated in an
international primary care setting (ICBP-M3) [20, 25].
Evidence suggests that using vignettes in a survey corre-
lates well in clinical practice [26]. The GPs were aware
that the questionnaires aimed to evaluate a CME in early
cancer diagnosis, and their responses might have been
different in a blinded study. Such potential information
bias may affect both baseline and follow-up responses in
each of the two GP groups, but it is difficult to assess in
which direction this may have affected the findings.
A limitation of the study is the modest response rate.
As a consequence, selection bias may also affect the
findings. We found evidence of such selection bias, but
the effect is difficult to establish. Another limitation is
Table 5 The CME effect on GP cancer risk assessment when referring consecutive patients for urgent referral. The numbers of
assessing GPs and assessed patients are shown together with the median (inter quartile interval (IQI)) and the mean (95 % CI) assessed
risk of cancer before and after the CME. GPs are divided into two groups: CME-participating group and reference group. An effect within
a group and comparisons between groups are shown as regression coefficients
Reference group CME-participating group Comparison
between
groups
N = 634 N = 197





GPs (n (%)) 384 (60.6) 364 (57.4) 148 (75.1) 160 (81.2)
Patients (n) 1740 1276 610 838
Median risk (% (IQI)) 30 (10–50) 30 (10–50) 30 (10–50) 15 (10–50)
Mean risk (% (95 % CI)) 39.6 (38.1; 41.0) 38.8 (37.1; 40.4) −0.17 (0.063) 39.0 (36.6; 41.4) 27.4 (25.6; 29.3) −1.10 (<0.001) −0.93 (<0.001)
Bold = significance level of p < 0.05. *adjusted for a study-step and patient’s gender and age, on square root scale
Table 4 The CME effect on GPs’ self-assessed readiness to investigate. The proportions of vignettes where the GP made a definitive
action after first or second phase of the vignette; one month before (Before) and seven months after (After) the CME. GPs are divided
into two groups: CME-participating group and reference group. An effect within a group is shown as an odds ratio (OR0 for
the Reference group; OR1 for the CME-participating group). Comparisons between groups are shown as a ratio of odds ratios (OR1/OR0)
Reference group
N (vignettes) = 232
N (GPs) = 116
CME-participating group
N (vignettes) = 160




Before After Before vs. after Before After Before vs. after OR1/OR0*
(p)% (n) % (n) OR0* (p) % (n) % (n) OR1* (p)
Definitive action, at the end of first phase 37.9 (88) 40.1 (93) 1.19 (0.444) 36.9 (59) 43.8 (70) 1.70 (0.055) 1.43 (0.316)
Definitive action, at the end of second phase 77.2 (179) 77.6 (180) 1.04 (0.872) 81.9 (131) 88.8 (142) 2.02 (0.043) 1.94 (0.119)
Bold = significance level of p < 0.05. *adjusted for a study-step and type of vignette
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the low participation in the CME. GPs may generally se-
lect educational activities in areas of their interest and
thus may already perform well in these areas [27].
Nevertheless, in this study, the reference GPs tended to
response more appropriately at baseline, but we found
no statistically significantly differences between the two
groups when comparing the baseline responses.
Apart from GP knowledge and referral threshold, the
GP-assessed cancer risk of an urgently referred patient
depends on e.g. suspected cancer type, symptom sever-
ity, symptom duration and genetic disposition for cancer
in combination with patient’s age and gender. As we
included nearly 4,500 urgently referred patients and ad-
justed for patient age and gender, the lack of adjustment
can be neglected due to an equal variation of patients in
each of the two GP groups both before and after the
CME. The strategy of reminding the GPs of possible
urgent referrals every second week on the basis of
hospital registers ensured data completeness. Before
being reminded, the reference GPs completed 40.0 %
before and 38.6 % after the CME of the one-page forms,
whereas the CME-participating GPs completed 47.2 %
before and 50.2 % after the CME (not reported in the
tables). Recall bias may have occurred when GPs were
reminded as a later response may mean that the result
of the investigation was known. However, the propen-
sities of the prospective data were almost unchanged
from before to after within group. Between groups, mis-
classification may exist as reference GPs responded less
prospectively than the CME-participating GPs which
may tend to underestimate the CME-effect.
The national strategy to improve early diagnosis of
cancer included a lowering of the GPs’ threshold for
referring patients for further investigation. Our study in-
dicated such an effect of the CME, which improved the
GP-assessed cancer risk of a patient suspected for cancer
at the time of referral. As the GPs had high baseline
knowledge on diagnostic pitfalls and initial cancer
presentation, the ceiling effect made it difficult to
demonstrate an effect. Improvements may still be
clinically relevant but the ceiling needs to be taken
into account when deciding on interventions strat-
egies, including considerations of making such CME
activities compulsory.
Comparison with other studies
To our knowledge, our study is the first to evaluate a
comprehensive and primary-care-based intervention on
knowledge, attitudes and intended behaviour related to
earlier cancer diagnosis, with the same participants and
intervention. However, some studies have assessed parts
of our intervention. The use of RATs in general practice
was evaluated in the UK and was associated with in-
creased diagnostic activity [28]. In Denmark, the use of
RAT for lung cancer as part of a CME was associated
with increased referral rate to direct chest CT scan [29].
It is unknown whether the effect found in our study may
persist over time. Still, the follow-up of 7 months is longer
than in many other studies of educational effects [12].
Conclusion
The CME lowered the GP-assessed cancer risk of
urgently referred patients and showed a limited effect on
GPs’ knowledge about cancer diagnosis and attitude
towards own role in cancer detection; the CME had no
effect on self-assessed readiness to investigate and GPs’
attitude towards practical aspects of urgent referral. A
standardised CME may be effective in changing both GP
attitude and knowledge including risk assessment, which
may be drivers for change in the clinical performance.
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